Introduction
============

Hormone-binding proteins (HBPs) are proteins that selectively and non-covalently bind to hormone (as shown in Figure [1](#F1){ref-type="fig"}) and carry hormone to target tissues to produce a desired effect [@B1]. HBPs were first recognized in plasma of pregnant mouse, rabbit and man a decade ago. They are associated with the regulation of the hormone supply in the circulatory system and affect the metabolism or behavior of other cells possessing functional receptors for the hormone. The sex HBPs produced mainly in the liver bind to sex steroid hormones and thereby regulate their bioavailability [@B2]. The abnormal expression of HBPs always causes various diseases[@B3]. Thus, it is important to clarify the function of HBPs and their regulation mechanisms.

The first step to study HBPs\' function is to accurately identify HBPs. However, with more and more proteins generated in the postgenomic age, it is difficult to determine HBPs with biochemical experiments due to expensive experimental materials and long experimental period. Computational methods are a good choice for timely and accurately identifying HBPs. Several machine learning methods, such as support vector machine (SVM), Mahalanobis discriminant (MD), increment of diversity (ID), neural network (NN) and random forest (RF), have been widely used in immunoglobulin prediction [@B5], apolipoprotein prediction [@B6], cell-penetrating peptides prediction [@B7], protein subcellular localization [@B8]-[@B14], conotoxin classification [@B15]-[@B17], ion channel prediction [@B18], [@B19], protein structure prediction [@B20]-[@B25], promoter prediction [@B26], [@B27], prediction of the origin of replication [@B28], [@B29] and the prediction of protein, DNA and RNA modification sites [@B30]-[@B33]. These methods do provide a great convenience to scholars. However, to the best of our knowledge, there is no computational method for HBP identification. The study aims to develop a new predictor for identifying HBPs.

According to previous comprehensive methods [@B34], the following five steps were conducted in this work to establish a statistical predictor for HBP identification. Firstly, functional HBPs were selected to construct a valid benchmark dataset to train and test the proposed method. Secondly, dipeptide composition which could truly reflect the residue correlation was extracted to formulate the protein samples. Thirdly, analysis of various (ANOVA)-based technique was used to rank these features. Fourthly, a widely used engine in bioinformatics, support vector machine, was selected to perform the prediction. Fifthly, the jackknife cross-validation was then used to objectively evaluate the anticipated accuracy of the predictor. In addition, based on the proposed model, we established a user-friendly web-server called **HBPred** for the identification of HBPs. These steps are introduced below.

Materials and Methods
=====================

Benchmark Dataset
-----------------

In a statistical predictor, enough related functional data should be collected to obtain prior knowledge. Thus, it is important to construct an objective benchmark dataset to guarantee the robustness of the model. However, to our knowledge, no database for HBP was published. Thus, we searched and collected HBPs from the Universal Protein Resource (UniProt) [@B35], which provide a stable, comprehensive, and freely accessible central resource of protein sequences and functional annotations. Firstly, we selected the hormone-binding keyword in molecular function item of Gene Ontology (GO) to generate original HBP dataset. Then, a total of 2460 HBPs were obtained. Subsequently, in order to improve the reliability of the dataset, the 2104 HBPs which were not manually annotated or reviewed were excluded. Finally, in order to avoid the redundancy which affected the accuracy estimation of the prediction model, we used CD-HIT [@B36], which had been widely used to cluster and compare protein or nucleotide sequences, to remove highly similar HBP sequences by setting the cutoff threshold to 0.6. In fact, a more objective dataset could be produced when the cutoff threshold was set to 0.25. However, in this study, we did not use such a stringent criterion because the currently available data did not allow the strict criterion. Otherwise, the number of proteins would be too few to have statistical significance. As a result, a total of 123 HBPs were obtained and regarded as positive data. As a control, non-HBPs were obtained by using the similar selection strategy. For the purpose of keeping a balance between positive data and negative data and providing an objective evaluation model, 123 non-HBPs were randomly selected from UniProt as negative data. The identity between any two sequences in non-HBPs was also less than 60%. The positive and negative datasets can be formulated as

,

where the subset ![](ijbsv14p0957i002.jpg) contains 123 HBPs; ![](ijbsv14p0957i003.jpg) contains 123 samples of non-HBPs; the symbol ⋃ represents the union in the set theory. All the data can be obtained from our website <http://lin-group.cn/server/HBPred/download.html>.

Sample descriptions
-------------------

For a HBP **P** with *L* residues, how do we translate it into a mathematical expression for statistical prediction? This is the second important step to develop a predictor for identifying HBP. Based on a widely accepted viewpoint that the protein sequence contains key information which could determine the protein\'s structure and function, we extracted the features from the primary sequence of HBPs and non-HBPs. The most straightforward method is to formulate a HBP **P** with *L* residues by using the residue sequence as:

P

=R

1

R

2

R

3

R

4

... R

L

,

where R~1~ represents the 1st residue of the HBP; R~2~ the 2nd residue of the protein, and so forth.

A straightforward method to perform statistical prediction is to utilize the search tools based on sequence similarity, such as FASTA and BLAST. However, when there is no similar sequence in the training dataset for a query HBP, the similarity-based method fails. Machine learning methods can overcome such disadvantage. However, in these machine learning-based methods, protein samples should be translated into vectors with the same dimension. Generally, a simple vector used to represent a protein sample is its amino acid composition (AAC) or residue composition:

,

where**T** is the transpose operator; ![](ijbsv14p0957i005.jpg) is the normalized occurrence frequency of the *i*-th type of native residue in the protein chain and can be calculated as

;

where ![](ijbsv14p0957i007.jpg) is the occurrence number of *i*-th residue in the protein **P**.

The AAC feature has been widely used in protein bioinformatics [@B12], [@B37]-[@B39]. However, AAC feature does not contain the sequence order information so that the prediction quality is always far from satisfactory. To include the correlation information between two residues, we consider the dipeptide composition which describes the correlation between two most contiguous amino acid residues. Thus, a HBP **P** can be expressed as a 400-dimensional vector (20×20=400):

,

where the component ![](ijbsv14p0957i009.jpg) and **T** is the transpose operator. Each component is given by

,

where A, C, ..., W, and Y are respectively the single letter codes of 20 native amino acids; ![](ijbsv14p0957i011.jpg) is the occurrence number for the dipeptide AA in the protein sequence (Eq. (2)); ![](ijbsv14p0957i012.jpg) for the dipeptide AC, and so forth.

Feature ranking technique
-------------------------

From Eqs. (5-6), a total of 400 dipeptide frequencies were calculated. In previous studies [@B40]-[@B46], some features were noise or redundant information. In fact, in statistical learning, for high-dimensional features, it is widely accepted that many features have no or even negative contribution to the classification. Thus, it is necessary to rank the features and evaluate the contribution of every feature to the classification. According to the statistical theory, ANOVA can be used to investigate the statistical significance of ratio of between groups variance and within groups variance [@B47]. Thus, the ratio called*F*-score is used to describe the contribution of each feature as:

,

where ![](ijbsv14p0957i014.jpg), ![](ijbsv14p0957i015.jpg), and ![](ijbsv14p0957i016.jpg) are the means of dipeptide *k* frequencies in all samples, HBP samples and non-HBP samples, respectively. Thus, the numerator and denominator in Eq. (7) denote the variances between groups and within groups, respectively. It is obvious that the larger the *F*(*k*) is, the better prediction capability the feature *k* has. Thus, the 400 dipeptides can be ranked according to their *F*-scores.

Support vector machine (SVM)
----------------------------

In the construction of a predictor of HBPs, the third important step is to discriminate HBPs from non-HBPs with a powerful predictive algorithm. The powerful and popular SVM in bioinformatics [@B48]-[@B56] was utilized in the study. The method was developed by Vapnik and his colleagues based on the statistical learning theory [@B57]. By projecting samples with low-dimensional feature into a high-dimension Hilbert space, it searches and constructs a separating hyperplane which could classify positive and negative samples with the maximal margin in the space by using the decision function:

,

where ![](ijbsv14p0957i018.jpg) is the *i*-th training vector; ![](ijbsv14p0957i019.jpg) represents the type of the *i*-th training vector; ![](ijbsv14p0957i020.jpg) is called a kernel function which defines an inner product in a high dimensional feature space. The radial basis kernel function (RBF) defined as ![](ijbsv14p0957i021.jpg) was used in the work because it was more suitable for nonlinear classification than other kernel functions. A free software package LibSVM, which could be freely downloaded from <http://www.csie.ntu.edu.tw/~cjlin/libsvm> [@B58], was used to implement the SVM. Grid search was performed with a miscellaneous tool based on LIBSVM called grid.py for optimizing the regularization parameter *C* and kernel parameter ![](ijbsv14p0957i022.jpg). The search spaces for *C* and ![](ijbsv14p0957i023.jpg) are:

,

where ![](ijbsv14p0957i025.jpg) and ![](ijbsv14p0957i026.jpg) denote the step gaps for *C* and ![](ijbsv14p0957i027.jpg), respectively.

Performance Evaluation
----------------------

A suitable statistical test is extremely important in the performance evaluation of the proposed model. In the study, the jackknife cross-validation test is used to evaluate the proposed model because it is more suitable for small sample sizes and always yields a unique result for a given benchmark dataset [@B59]-[@B62]. The following three indexes called Sensitivity (*Sn*), Specificity (*Sp*) and Overall Accuracy (*OA*) were used:

where ![](ijbsv14p0957i029.jpg) and ![](ijbsv14p0957i030.jpg) are the number of the correctly identified HBPs (also called true positives) and the number of the correctly identified non-HBPs (also called true negatives), respectively.

Results
=======

Prediction Performance
----------------------

We firstly investigated the prediction performance of 400 dipeptide compositions on the discrimination between HBPs and non-HBPs through the jackknife cross-validation test. We found that the overall accuracy reached maximum (75.6%) when *C*=2 and ![](ijbsv14p0957i031.jpg).

Generally, high-dimensional features contain more information for HBPs. However, these features also contain noise or redundant information, which results in the poor predictive capabilities on HBP prediction in the cross-validation test [@B11]. We thought that the HBP prediction accuracy could be further improved by noise exclusion. Therefore, we used ANOVA-based feature selection technique to find out the best feature subset which produced the maximum accuracy for distinguishing HBPs from non-HBPs. The*F*-scores of 400 dipeptides were calculated according to Eq. (7). Then, we ranked the 400 dipeptides according to the decreasing order of their *F*-scores:

,

where the ![](ijbsv14p0957i033.jpg) is the first dipeptide with the maximum *F*-score; ![](ijbsv14p0957i034.jpg) is the second dipeptide with the second maximum *F*-score; ![](ijbsv14p0957i035.jpg) is the third dipeptide with the third maximum *F*-score and so forth; **T** is the transpose operator.

Subsequently, we utilized the incremental feature selection (IFS) strategy [@B5], [@B18], [@B19] to find out the optimal features which are the best for HBP prediction based on the following steps. Firstly, we obtained 400 feature subsets. The first feature subset only contained the first dipeptide in the ranked set **D** and arbitrary sample can be formulated as ![](ijbsv14p0957i036.jpg). The second feature subset contains the first and second dipeptides in the ranked set and arbitrary sample can be formulated as ![](ijbsv14p0957i037.jpg), and so on. It is obvious that the 400^th^ feature subset contains 400 dipeptides whose accuracy has been achieved above. Secondly, all the 400 feature subsets were inputted into SVM for classification. The jackknife cross-validation test was used to evaluate all 400 models. A total of 400 *OA*s were obtained. The maximum *OA* can be easily observed by plotting the ISF curve in **Figure [2](#F2){ref-type="fig"}**. When the top 73 dipeptides were used as inputs, the maximum *OA* of 84.9% could be obtained. We also noticed that the 86^th^ feature subset could also produce the *OA* of 84.9% in the jackknife cross-validation test (Blue dot in **Figure [2](#F2){ref-type="fig"}**). Here, we used the 73^th^ feature subset to construct the final prediction model because it contained fewer features than the 86^th^ feature subset. These 73 dipeptides had the higher *F*-scores, meaning that they had the high confidence level and could give more reliable information for classification. In addition, we investigated the *Sn* and *Sp*, which were 88.6% and 81.3%, respectively. The parameters*C* and ![](ijbsv14p0957i038.jpg) were 8 and 0.03125, respectively.

In general, the dipeptides with high *F*-score give more reliable information for classification. Thus, we extracted the top 20 dipeptides with the maximum *F*-score to investigate their performance on HBP prediction. The *OA* reached 80.1% in jackknife cross-validation test (Green dot in **Figure [2](#F2){ref-type="fig"}**). However, the number of features is too small to provide enough information, thus resulting in the poor performance of 20 best dipeptides compared with 73 best dipeptides.

Feature analysis
----------------

To provide a visible and direct analysis on the contributions of different dipeptides in the prediction model, we drew a heat map (**Figure [3](#F3){ref-type="fig"}**) representing a matrix in which the elements represented the features and were encoded with different colors according to their ![](ijbsv14p0957i039.jpg) defined as [@B6], [@B47]

,

where *F*~min~ and *F*~max~ are the minimum and maximum *F*-scores of the 400 dipeptides; ![](ijbsv14p0957i041.jpg) and ![](ijbsv14p0957i042.jpg) are the average frequencies of the *k*^th^ dipeptide in HBP dataset and non-HBP dataset, respectively; sgn is the sign function. Thus, the upper limit and lower limit of ![](ijbsv14p0957i043.jpg) are 1 and -1, respectively. The first and second residues of 400 dipeptides are respectively listed in the row and column of the heat map. It is obvious that if ![](ijbsv14p0957i044.jpg), the *k*^th^ dipeptide prefers HBP, otherwise it prefers non-HBP. In Figure [3](#F3){ref-type="fig"}, the dipeptides in red and blue boxes are positively and negatively correlated with HBPs, respectively. The redder the element is, the more highly relevant with HBPs it is, and vice versa. From the figure, we found that HBPs contained the more abundant residues of Cys (C), His (H), Lys (K), Thr (T), Asn (N) and Arg (R) (red) than non-HBPs, whereas non-HBPs contained the more abundant residues of Leu (L), Phe (F), Trp (W), and Tyr (Y) (blue).

Discussion
==========

The purpose of the work is to develop a powerful tool to accurately recognize HBPs. Currently, the approaches for protein function prediction mainly contain two kinds of strategies. The one is based on similarity search. Another is on the basis of machine learning method. In the first strategy, the query sequence is aligned with the sequences in benchmark dataset to find out highly similar sequences or homologues. Some famous tools such as BLAST and FASTA are generally used to perform the sequence alignment. Their advantage is not affected by sequence length. Although this kind of sequence model is straightforward and intuitive, unfortunately, it fails when a query sequence does not have significant similarity to any of the peptide sequences in the training dataset.

The machine learning-based method can overcome the disadvantage by transferring any sequence into a vector with the same dimension. Many feature models, such as amino acid composition (AAC) [@B37], *n*-mer peptide composition [@B8], [@B50], [@B63], [@B64], *g*-gap dipeptide composition [@B6], [@B12], [@B47], and pseudo amino acid composition (PseAAC) [@B5], [@B9], [@B10], [@B43], [@B65], [@B66], have been proposed to formulate protein sequences. For the purpose of improving protein function prediction, some scholars used Position-Specific Scoring Matrix (PSSM) [@B3], [@B67]-[@B71] and gene ontology (GO) [@B72]-[@B74] to describe protein samples. Although PSSM and GO always produced the high accuracy for protein classification, formulating protein samples with the methods generally led to significant flaws. PSSM is generated with the software PSI-BLAST [@B75], a similarity search tool. Therefore, it is necessary to search for a query protein in a big dataset (usually UniProt or SwissProt) by using PSI-BLAST. In most cases, the big dataset contains the query protein. Thus, the cross-validated results with machine learning method are not objective or strict. If the dataset did not contain the query sequence, but there was similar sequence in the dataset, we accepted the cross-validated results. However, it is time-consuming and not necessary to input PSSM into classifier because the BLAST or FASTA can give more accurate and straightforward results. Furthermore, if the dataset did not contain query sequence or similar sequence, the PSSM could not correctly reflect the consensus motif, thus resulting in wrong prediction.

We also thought that GO information was not suitable for the HBP prediction due to the following factors. The GO is designed to describe gene function along three aspects: molecular functions (molecular activities of gene products), cellular components (where gene products are active) and biological processes (pathways and processes of the activities of multiple gene products). The computational approaches of identifying protein type aim to determine protein functions. In other words, our computational approaches should be able to predict the GO information of proteins. If the GO information of one protein or its homologues has been annotated, it is not necessary to predict the function of the protein. Thus, using GO information to predict protein function likes putting the cart before the horse. Besides, the dimension of GO information can increase when new GO node is added. Thus, any old GO-based model cannot handle such feature. Therefore, the two features are not adopted in our model. In fact, the sequence information is the most objective feature in sample descriptions, which also obey the theoretical biology route (also called reverse biology route) that sequence determines structure, and structure determines function.

To provide the convenience for the most of wet-experimental users, a user-friendly web-server called **HBPred** was established based on above calculations. The web server can be freely accessed at <http://lin-group.cn/server/HBPred>. The prediction page is shown in **Figure [4](#F4){ref-type="fig"}**. One may firstly upload a sequence file or paste protein sequences in the FASTA format into the input box. Then, after clicking the button of "submit", the predicted results will be obtained.

Conclusion
==========

We constructed an effective predictor to identify HBPs. Encouraging accuracy was achieved. We also discussed why PSSM or GO information was not suitable for HBP prediction. A free webserver could provide convenience to most of wet-experimental scholars [@B76]-[@B80]. Thus, finally, we established a new tool, called **HBPred**, to accurately predict potential novel HBPs. We expect that the tool will help scholars to improve drug development in relevant diseases. In the future, we will perform the prediction on the subtypes of HBPs.
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![Schematic diagram of human growth hormone (red) binding to two HBPs (yellow) [@B4]](ijbsv14p0957g001){#F1}

![IFS curve for discriminating HBPs from non-HBPs. When the top 73 dipeptides were used to perform prediction, the overall success rate (Red dot) reaches an IFS peak of 84.9% in jackknife cross-validation. Another IFS peak (Blue dot) is observed when the abscissa is 86 (namely, 86 features). The green dot denotes the results obtained with 20 features.](ijbsv14p0957g002){#F2}

![Heat map or chromaticity diagram for the *F*-scores of the 400 dipeptides. Red elements indicate the dipeptides enriched in HBPs, whereas blue elements indicate the dipeptides enriched in non-HBPs.](ijbsv14p0957g003){#F3}
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